PCTAIRE-1 Activators
PCTAIRE-1 activators constitute a chemical class designed to modulate the activity of PCTAIRE-1, a serine/threonine protein kinase that belongs to the cyclin-dependent kinase (CDK) family. Although originally discovered in the context of cell cycle regulation, PCTAIRE-1's precise biological functions remain an active area of investigation, and they are thought to extend beyond the traditional roles typically associated with CDKs. The PCTAIRE-1 protein is of particular interest to researchers focusing on the mechanisms of cellular signaling and regulation.
The activation of PCTAIRE-1 by these activators may be achieved through various biochemical interactions. Some activators may bind directly to PCTAIRE-1, promoting its kinase activity. This direct binding can either stimulate the active site of the enzyme, enhance substrate recognition, or alter the protein's conformation to a state that favors activation. Alternatively, other activators may work indirectly, possibly by influencing the expression levels of PCTAIRE-1 or its associated proteins, such as cyclins, or by disrupting inhibitory interactions that prevent PCTAIRE-1 from reaching its fully active state. Given the kinase activity of PCTAIRE-1, its activators are invaluable tools in the study of phosphorylation-dependent signaling pathways. The phosphorylation of proteins by kinases such as PCTAIRE-1 can alter a protein's function, stability, localization, or interaction with other proteins, thereby affecting various cellular processes. By studying PCTAIRE-1 activators, researchers can gain insight into the kinase's role in these processes and map out the signal transduction pathways in which it participates.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can lead to the activation of cAMP-dependent protein kinase A (PKA). PKA can then phosphorylate PCTAIRE-1, enhancing its kinase activity and possibly its interactions with other proteins. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a phosphodiesterase-4 inhibitor that prevents cAMP degradation, leading to increased PKA activity. PKA phosphorylation can enhance PCTAIRE-1 activity by increasing its phosphorylation state, thereby activating its kinase function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate cellular differentiation and proliferation pathways. It may upregulate the expression of PCTAIRE-1 through retinoic acid receptors, which can bind to the gene's promoter region, indirectly enhancing its protein activity. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
(S)-(-)-Blebbistatin inhibits non-muscle myosin II ATPase activity, affecting cytoskeletal dynamics. These changes can potentially activate PCTAIRE-1 by altering its subcellular localization or its association with specific substrates or regulators. | ||||||
PD 0332991 Isethionate | 827022-33-3 | sc-478943 | 1 mg | $300.00 | ||
PD 0332991 specifically inhibits CDK4/6, which could shift the cell cycle regulatory balance and indirectly enhance the activity of PCTAIRE-1 by allowing an increased association with necessary cyclins or substrates in overlapping pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a Rho-associated protein kinase inhibitor, which can lead to changes in actin cytoskeleton organization. This may indirectly enhance PCTAIRE-1 activity by modulating its interactions with cytoskeletal-associated proteins or pathways. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor that could affect cell cycle progression and mitotic spindle assembly. These alterations may enhance PCTAIRE-1 activity by modifying its kinase domain's accessibility or altering its substrate specificity. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB 216763 is a GSK-3 inhibitor that impacts Wnt signaling and cellular proliferation. Inhibition of GSK-3 may lead to enhanced activity of PCTAIRE-1, by altering the phosphorylation state of proteins within the same or intersecting signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters AKT signaling and may affect downstream processes like cell cycle progression. This alteration could enhance PCTAIRE-1 activity by modifying its interaction with proteins that are part of the AKT pathway. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). Its inhibition can lead to altered calcium signaling, potentially enhancing PCTAIRE-1 activity by changing the phosphorylation dynamics of associated proteins. | ||||||